
Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis
Introduction Intra-patient variability (IPV) in tacrolimus blood concentrations has emerged as a potential biomarker for